Crude incidence rates of stroke and all-cause mortality. by Simon de Lusignan (2416)

Subjects:

Time-Varying effect of anti-coagulation regimen on sub-distribution hazards for stroke. by Simon de Lusignan (2416)

Subjects:

Unadjusted cumulative incidence of stroke and all-cause mortality. by Simon de Lusignan (2416)

Subjects:

Multivariate analysis of the cause-specific hazard ratio (CSHR) for all-cause mortality, interpreted as time-averaged effects. by Simon de Lusignan (2416)

Subjects:

Multivariate analysis of the cause-specific hazard ratio (CSHR) for stroke. by Simon de Lusignan (2416)

Subjects:

Change in use of Warfarin and DOACs over time, financial incentives to encourage increased detection in the management of AF introduced in 2014. by Simon de Lusignan (2416)

Subjects:

NADPH oxidase–derived ROS promote skin inflammation in Spint1a-deficient larvae. by Francisco J. Martínez-Morcillo (11663364)

Western blot analysis of MPK-1 levels in <i>isp-1</i> and <i>nuo-6</i> mutants. by Maximilian Kramer-Drauberg (8981141)

“…MPK-1b level was significantly decreased in <i>nuo-6</i> and <i>nuo-6; let-60gf</i> compared to wild-type. …”

Motifs significantly enriched in decreased ATAC peaks relative to unchanged ATAC peaks at 30 minutes. by Thomas G. Scott (4092892)

CRISPRi knockdown of RgaR-dependent genes specifically and significantly decreases their transcript levels. by Adrianne N. Edwards (5646344)

Fig 1 - by Byung Chul Kang (1905025)

Subjects:

<i>hdc</i> depletion in progenitors triggers ROS production, but does not activate Foxo and insulin/mTOR. by Bayan Kharrat (19959505)

Top 20 genes with significantly decreased abundance in Aco^R cells. by Pieter C. Steketee (10024552)

Subjects:

Loss of SID-1 and/or SID-3 functionality decreases DA neurodegeneration and improves DA neuron function. by Anthony L. Gaeta (13272609)

Characterization of the controlled cortical impact model and selection of sub-convulsive dose of PTZ. by Simone A. A. Romariz (16541996)

Subjects:

Delayed treatment with ceftriaxone increases glutamate transporter mRNA in cortex and hippocampus. by Simone A. A. Romariz (16541996)

Subjects:

Modified Racine score for PTZ-induced seizures. From [28]. by Simone A. A. Romariz (16541996)

Subjects:

Time-dependent effects of CCI on glutamate transporter mRNA. by Simone A. A. Romariz (16541996)

Subjects:

Chronic, but not acute, CCI mice have increased susceptibility to 30mg/kg PTZ. by Simone A. A. Romariz (16541996)

Subjects:

Delayed treatment with ceftriaxone reduced seizure susceptibility in CCI mice. by Simone A. A. Romariz (16541996)

Subjects: